Related Experiment Video
Updated: Apr 27, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
17.1K
Tuberculosis treatment in patients with comorbidities
1Division of Pulmonology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Tuberculosis and Respiratory Diseases
|July 16, 2014
Summary
Tuberculosis poses a significant risk for elderly Koreans with underlying health conditions like cancer and diabetes. Careful monitoring of treatment toxicity and effectiveness is crucial for these patients.
Area of Science:
- Infectious Diseases
- Geriatrics
- Public Health
Background:
- Tuberculosis (TB) presents a substantial challenge in elderly individuals, particularly those with co-existing medical conditions in Korea.
- Age-related diseases, including malignancy and diabetes mellitus, are identified as potential risk factors for developing TB in this demographic.
- Managing TB in elderly patients with comorbidities is complicated by the potential for adverse drug reactions and suboptimal treatment outcomes.
Purpose of the Study:
- To highlight the challenges of tuberculosis treatment in elderly patients with comorbidities.
- To emphasize the increased risk of TB in this population due to age-associated diseases.
- To underscore the necessity for vigilant clinical monitoring of antituberculosis therapy.
Main Methods:
- This study is a review of existing literature and clinical observations regarding tuberculosis in elderly patients with comorbidities.
- Analysis of epidemiological data and treatment outcomes in the Korean elderly population.
- Evaluation of adverse drug reactions and treatment efficacy in the context of multiple comorbidities.
Main Results:
- Elderly patients with comorbidities, such as malignancy and diabetes, exhibit a higher susceptibility to tuberculosis.
- Antituberculosis drug regimens in this population are associated with increased risks of adverse reactions.
- Treatment efficacy can be compromised, necessitating close clinical supervision.
Conclusions:
- Tuberculosis management in elderly Koreans with comorbidities requires a tailored approach.
- Close monitoring for both drug toxicity and treatment effectiveness is paramount.
- Further research into optimized treatment strategies for this vulnerable group is warranted.
More Related Videos
Related Concept Videos
01:28Pulmonary Tuberculosis V
978
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
978
01:29Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
01:31Pulmonary Tuberculosis III
1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
01:26Pulmonary Tuberculosis IV
810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
01:28Pulmonary Tuberculosis II
2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
01:28Pneumonia IV: Management
1.2K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K